Tesaro (TSRO) in Focus: Stock Adds 13.4% in Session

Zacks

Tesaro, Inc. (NASD:TSRO) was a big mover last session, as its shares rose over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Jan 6, as the stock is now up 50%.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Tesaro currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Grifols, S.A. (NASD:GRFS), Endocyte, Inc. (NASD:ECYT) and Lannett Company, Inc. (NYSE:LCI). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


TESARO INC (TSRO): Free Stock Analysis Report

GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)